AstraZeneca shares fall on report of potential China probe fallout

AstraZeneca shares fall on report of potential China probe fallout


The Astrazeneca logo is pictured at the World Artificial Intelligence Conference 2021 in Shanghai, China, July 7, 2021.

Costfoto | Future Publishing | Getty Images

AstraZeneca shares on Tuesday recorded their worst day since March 2020 after a report that dozens of the drugmaker’s senior executives in China could be implicated in the largest insurance fraud case in the country’s pharma sector in years.

The Anglo-Swedish company, which has invested heavily in the world’s No. 2 pharmaceuticals market, said last week that its China president, Leon Wang, was under investigation and that the drugmaker would cooperate with authorities.

AstraZeneca had not said what the investigation was about or whether Wang, who grew up in China and has been with the company for more than a decade, had been detained by authorities.

The investigation by Chinese authorities has now expanded to include the public security bureau, supervisory commission and other relevant bodies, financial media company Yicai reported on Tuesday, citing a person familiar with the matter.

The report added that medical representatives have been previously found to fake prescriptions for AstraZeneca’s lung cancer drug, Tagrisso, to allow patients to buy it through the state’s medical insurance program.

“As a matter of policy, we do not comment on speculative media reports including those related to ongoing investigations in China,” AstraZeneca said.

“If requested, we will fully cooperate with the Chinese authorities,” the company added and said that its operations and delivery of medicines were ongoing in China.

AstraZeneca is one of the biggest multinational drugmakers in China, which accounts for 13% of its overall revenue. It said last year it would build a $450 million factory in the country and has also signed several licensing deals with Chinese firms.

However, AstraZeneca’s more than 30-year presence in the country has not been without challenges over prescriptions and sales.

In 2022, Chinese authorities had summoned AstraZeneca officials over an investigation of suspected medical insurance fraud by its employees, and had ordered that the drugmaker tighten its marketing activities.

The FTSE 100 component fell as much as 8.4% on Tuesday to hit a seven-month low of 10,118 pence and was the second-biggest percentage loser on the blue-chip index.



Source

Amazon Web Services outage takes down major websites
World

Amazon Web Services outage takes down major websites

Amazon Web Services Inc. signage at the Nvidia GPU Technology Conference in San Jose, California, on March 20, 2025. David Paul Morris | Bloomberg | Getty Images Amazon Web Services, a leader in the cloud infrastructure market, reported a major outage on Monday, taking down numerous big-name websites. AWS cited an “operational issue” affecting “multiple […]

Read More
Trump calls for Ukraine to be ‘cut up’ after tense meeting with Zelenskyy
World

Trump calls for Ukraine to be ‘cut up’ after tense meeting with Zelenskyy

U.S. President Donald Trump welcomes Ukraine’s President Volodymyr Zelenskyy at the White House in Washington, D.C., U.S., October 17, 2025. Jonathan Ernst | Reuters U.S. President Donald Trump has signaled a shift in support toward Russia’s Vladimir Putin as he looks for a quick end to the war in Ukraine, likely striking fear into Ukrainian […]

Read More
European markets start the week higher, shrugging off credit concerns
World

European markets start the week higher, shrugging off credit concerns

The City of London financial district at sunrise. Alexander Spatari | Moment | Getty Images LONDON — European stocks were in positive territory on Monday morning after a volatile few days in which investors weighed concerns over bad loans on Wall Street. The pan-European Stoxx 60 was up about 0.8% at 8:30 a.m. in London […]

Read More